In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nexavar, Bay 43-9006, Sorafenib Tosylate Drug Master File in Korea (Nexavar, Bay 43-9006, Sorafenib Tosylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nexavar, Bay 43-9006, Sorafenib Tosylate. The MFDS reviews the Nexavar, Bay 43-9006, Sorafenib Tosylate KDMF as part of the drug registration process and uses the information provided in the Nexavar, Bay 43-9006, Sorafenib Tosylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nexavar, Bay 43-9006, Sorafenib Tosylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nexavar, Bay 43-9006, Sorafenib Tosylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nexavar, Bay 43-9006, Sorafenib Tosylate suppliers with KDMF on PharmaCompass.